Efficacy, toxicology and clinical applications of ribavirin against virulent RNA viral infections.
Canonico
P G
PG
D000284:Administration, Oral; D000818:Animals; D001102:Arbovirus Infections / Q000188:drug therapy*; D001116:Arenaviridae / Q000187:drug effects; D001117:Arenaviridae Infections / Q000188:drug therapy; D002417:Cattle; D002986:Clinical Trials as Topic; D006224:Cricetinae; D004195:Disease Models, Animal; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004660:Encephalitis / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D006476:Orthohantavirus / Q000187:drug effects; D006480:Hemorrhagic Fever with Renal Syndrome / Q000188:drug therapy; D006524:Hepatitis, Viral, Animal / Q000188:drug therapy; D006801:Humans; D008253:Macaca mulatta; D051379:Mice; D012328:RNA Viruses; D012254:Ribavirin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D012263:Ribonucleosides / Q000627:therapeutic use*; D012295:Rift Valley Fever / Q000188:drug therapy; D012296:Rift Valley fever virus / Q000187:drug effects / Q000472:pathogenicity; D014777:Virus Diseases / Q000188:drug therapy*
D012263:Ribonucleosides; D012254:Ribavirin